At a glance
- Originator Pharmacia Corporation
- Class Antivirals
- Mechanism of Action Alpha-glucosidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 16 May 2001 No-Development-Reported for HIV infections treatment in USA (Unknown route)
- 30 Nov 1994 Phase-II clinical trials for HIV infections treatment in USA (Unknown route)